{"disease":{"id":"alcohol-withdrawal-delirium","name":"Alcohol withdrawal delirium","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"diazepam","indication_name":"Alcohol withdrawal delirium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal delirium","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04156464","title":"Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":142,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT03586089","title":"Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome","phase":"NA","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT03877120","title":"Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Centro Medico Nacional La Raza, IMSS","has_results":false}],"total":3},"guidelines":[{"drug_id":"diazepam","guideline_body":"FDA label","recommendation":"Diazepam tablets may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null},{"drug_id":"diazepam","guideline_body":"FDA label","recommendation":"Diazepam tablets may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}